Clinical Trials for Urethral Melanoma

Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery

NCT ID: NCT05111574

This clinical trial is looking at whether a combination of two medications, nivolumab and cabozantinib, can help prevent the return of mucosal melanoma after surgery. Mucosal melanoma is a type of ...